.Merck beats incomes expectations, raises purchases expectation on powerful need for top drugs like Keytruda CNBCMerck & Co. (MRK US) Defeats Income Estimates as Keytruda Sales Surge BloombergMerck Inventory: Pharma Titan Posts Strong Outcomes, But Overview Falls Short Financier's Company DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck trumps income and also sales assumptions in the middle of Keytruda advantage, however gives blended full-year outlook MarketWatch.